These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30007114)

  • 21. Antiphospholipid antibodies and the antiphospholipid antibody syndrome.
    Nahass GT
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):149-68; quiz 169-72. PubMed ID: 9039162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to Interpret Antiphospholipid Laboratory Tests.
    Devreese KMJ
    Curr Rheumatol Rep; 2020 Jun; 22(8):38. PubMed ID: 32562091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princess.
    Pérez D; Tincani A; Serrano M; Shoenfeld Y; Serrano A
    Lupus; 2018 Feb; 27(2):177-178. PubMed ID: 29067871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of anti-domain 1- β
    Zhang S; Wu Z; Zhang F; Li Y
    J Thromb Haemost; 2016 Oct; 14(10):2076-2078. PubMed ID: 27455394
    [No Abstract]   [Full Text] [Related]  

  • 25. 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
    Cervera R; Rodríguez-Pintó I; Colafrancesco S; Conti F; Valesini G; Rosário C; Agmon-Levin N; Shoenfeld Y; Ferrão C; Faria R; Vasconcelos C; Signorelli F; Espinosa G
    Autoimmun Rev; 2014 Jul; 13(7):699-707. PubMed ID: 24657970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiphospholipid antibodies].
    Kaburaki J; Kuwana M; Ikeda Y
    Rinsho Byori; 2003 Jul; 51(7):639-43. PubMed ID: 12924247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comment on: "The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome".
    Yazici A; Unlu O; Erkan D
    Thromb Res; 2017 Sep; 157():82-83. PubMed ID: 28711777
    [No Abstract]   [Full Text] [Related]  

  • 28. Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of "Non-criteria" Antiphospholipid Antibodies.
    Zohoury N; Bertolaccini ML; Rodriguez-Garcia JL; Shums Z; Ateka-Barrutia O; Sorice M; Norman GL; Khamashta M
    J Rheumatol; 2017 Nov; 44(11):1597-1602. PubMed ID: 28864642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays.
    Favaloro EJ; Wong RC
    Clin Chem Lab Med; 2011 Mar; 49(3):447-61. PubMed ID: 21275808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-Density Granulocytes Are Increased in Antiphospholipid Syndrome and Are Associated With Anti-β2 -Glycoprotein I Antibodies: Comment on the Article by Yalavarthi et al.
    van den Hoogen LL; Fritsch-Stork RD; van Roon JA; Radstake TR
    Arthritis Rheumatol; 2016 May; 68(5):1320-1. PubMed ID: 26749538
    [No Abstract]   [Full Text] [Related]  

  • 31. Comment on: "A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies" by Niccolai et al.
    Rodríguez-Carrio J; López Suárez P; Suárez Díaz A
    Thromb Res; 2016 Mar; 139():127. PubMed ID: 26916309
    [No Abstract]   [Full Text] [Related]  

  • 32. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overrepresentation of Elderly Subjects in a Population-Based Study of Antiphospholipid Syndrome: Comment on the Article by Duarte-García et al.
    Gómez-Puerta JA; Cervera R; Alarcón GS
    Arthritis Rheumatol; 2019 Oct; 71(10):1768-1769. PubMed ID: 31131989
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comments on antiphospholipid antibody tests].
    Malícková K; Sandová P; Janatková I
    Epidemiol Mikrobiol Imunol; 2006 Nov; 55(4):158-63. PubMed ID: 17354591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome.
    Sciascia S; Naretto C; Rossi D; Bazzan M; Roccatello D
    Lupus; 2011 Oct; 20(10):1106-8. PubMed ID: 21652607
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiphospholipid antibodies and thrombosis.
    Greaves M
    Lancet; 1999 Apr; 353(9161):1348-53. PubMed ID: 10218548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Catastrophic antiphospholipid syndrome. Communication of 2 forms of presentation].
    Grinberg AR; Heller PG; Correa G; Sarano JF; Molinas FC; Nicastro MA; Alvarez CL
    Medicina (B Aires); 1999; 59(6):743-6. PubMed ID: 10752219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
    Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A
    Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent Developments in Antiphospholipid Antibodies and the Antiphospholipid Syndrome.
    Urbanus RT
    Semin Thromb Hemost; 2018 Jul; 44(5):417-418. PubMed ID: 29940673
    [No Abstract]   [Full Text] [Related]  

  • 40. The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis.
    Sciascia S; Willis R; Pengo V; Krilis S; Andrade D; Tektonidou MG; Ugarte A; Chighizola C; Branch DW; Levy RA; Nalli C; Fortin PR; Petri M; Rodriguez E; Rodriguez-Pinto I; Atsumi T; Nascimento I; Rosa R; Banzato A; Erkan D; Cohen H; Efthymiou M; Mackie I; Bertolaccini ML;
    Thromb Res; 2019 Mar; 175():32-36. PubMed ID: 30685523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.